153 related articles for article (PubMed ID: 31897163)
1. Survival benefit of nephron-sparing surgery for patients with pT1b renal cell carcinoma: A population-based study.
Liu X; Huang X; Zhao P; Zhang P
Oncol Lett; 2020 Jan; 19(1):498-504. PubMed ID: 31897163
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Partial and Radical Nephrectomy for pT1b Renal Cell Carcinoma.
Kim JM; Song PH; Kim HT; Park TC
Korean J Urol; 2010 Sep; 51(9):596-600. PubMed ID: 20856643
[TBL] [Abstract][Full Text] [Related]
3. Radical versus partial nephrectomy for T1 non-clear cell renal cell carcinoma.
Hu X; Wang Y; Shao Y; Wu K; Tang Y; Ren S; Li X
Eur J Surg Oncol; 2023 Aug; 49(8):1519-1523. PubMed ID: 36958950
[TBL] [Abstract][Full Text] [Related]
4. Oncological and functional efficacy of nephron-sparing surgery versus radical nephrectomy in renal cell carcinoma stages ≥cT1b: a single institution, matched analysis.
Veys R; Abdollah F; Briganti A; Albersen M; Poppel HV; Joniau S
Cent European J Urol; 2018; 71(1):48-57. PubMed ID: 29732207
[TBL] [Abstract][Full Text] [Related]
5. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
6. Oncologic and Functional Outcomes after Partial Nephrectomy Versus Radical Nephrectomy in T1b Renal Cell Carcinoma: A Multicenter, Matched Case-Control Study in Korean Patients.
Jang HA; Kim JW; Byun SS; Hong SH; Kim YJ; Park YH; Yang KS; Cho S; Cheon J; Kang SH
Cancer Res Treat; 2016 Apr; 48(2):612-20. PubMed ID: 26044158
[TBL] [Abstract][Full Text] [Related]
7. Partial and Radical Nephrectomy Provides Equivalent Oncologic Outcomes in pT3a Renal Cell Carcinoma: A Population-Based Study.
Tian J; Zeng X; Wan J; Gan J; Ke C; Guan W; Hu Z; Yang C
Front Oncol; 2021; 11():819098. PubMed ID: 35155208
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of partial versus radical nephrectomy for renal cell carcinoma: Is oncologic safety compromised during nephron sparing in higher stage disease?
Hakam N; Heidar NA; El-Asmar J; Khauli M; Degheili J; Al-Moussawy M; Nasr R; El-Hajj A; Wazzan W; Bulbul M; Khauli RB
Urol Ann; 2023; 15(2):226-231. PubMed ID: 37304513
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis for comparison of partial nephrectomy
Liu H; Kong QF; Li J; Wu YQ; Pan KH; Xu B; Wang YL; Chen M
Transl Androl Urol; 2021 Mar; 10(3):1170-1178. PubMed ID: 33850752
[TBL] [Abstract][Full Text] [Related]
10. Partial versus radical nephrectomy for T1b-2N0M0 renal tumors: A propensity score matching study based on the SEER database.
Zhang M; Zhao Z; Duan X; Deng T; Cai C; Wu W; Zeng G
PLoS One; 2018; 13(2):e0193530. PubMed ID: 29489911
[TBL] [Abstract][Full Text] [Related]
11. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
12. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
13. The Overall Survival Benefit for Patients with T1 Renal Cell Carcinoma after Nephron-Sparing Surgery Depends on Gender and Age.
Liek E; Elsebach K; Göbel H; Krah X; Krautschick-Wilkens AW; Schweiger J; Steiner G; Steiner T; Wunderlich H
Urol Int; 2018; 100(3):309-316. PubMed ID: 29502123
[TBL] [Abstract][Full Text] [Related]
14. Comparison of survival for partial vs. radical nephrectomy in young patients with T1a renal cell carcinoma treated at commission on cancer-accredited facilities and influence of comorbidities on treatment choice.
Wang DC; Plante K; Stewart T; Wang D; Formica M; Daugherty M; Bratslavsky G
Urol Oncol; 2017 Nov; 35(11):660.e9-660.e15. PubMed ID: 28736248
[TBL] [Abstract][Full Text] [Related]
15. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
16. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Outcome of Nephron-Sparing Surgery Compared to Radical Nephrectomy for Renal Cell Carcinoma ≥4 cm - A Matched-Pair Single Institution Analysis.
Kalogirou C; Fender H; Muck P; Hey V; Krebs M; Riedmiller H; Vergho D
Urol Int; 2017; 98(2):138-147. PubMed ID: 27505105
[TBL] [Abstract][Full Text] [Related]
18. Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.
An JY; Ball MW; Gorin MA; Hong JJ; Johnson MH; Pavlovich CP; Allaf ME; Pierorazio PM
Urology; 2017 Feb; 100():151-157. PubMed ID: 27889493
[TBL] [Abstract][Full Text] [Related]
19. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Thermal Ablation, Surgical Resection, and Active Surveillance for T1a Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked Population Study.
Xing M; Kokabi N; Zhang D; Ludwig JM; Kim HS
Radiology; 2018 Jul; 288(1):81-90. PubMed ID: 29737950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
